Test Price
1,800 AED✅ Home Collection Available
Immunosuppressant Drug Monitoring Panel (4-Drug Profile) in Dubai, UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified LC-MS/MS processing.
- Premium Logistics: Paid hospital-grade home collection with ISO-certified cold-chain transport and VIP mobile phlebotomy.
- Clinical Guidance: Complimentary telephonic post-test interpretation by a DHA-licensed general practitioner.
- Insurance: Direct billing verification – send your policy copy via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This quantitative panel measures blood trough levels of four critical immunosuppressants – cyclosporine, tacrolimus, sirolimus, and everolimus – using LC-MS/MS, the gold standard for therapeutic drug monitoring. It empowers nephrologists, transplant surgeons, and gastroenterologists to optimise dosing and prevent rejection or toxicity.
| Feature | Our Test (Premium DHA-Aligned) | Closest Alternative |
|---|---|---|
| Methodology | LC-MS/MS (FDA-compliant, free from immunoassay cross-reactivity) | Immunoassay platforms with known interference risks |
| Precision | 99.9% sensitivity at trough levels | Typical sensitivity ~85–90% |
| Speed | Same-day report (sample received by 5:00 PM) | Often 24–72 hours |
Physician Insight & Safety Protocols
Dr. Ajay Singh (DHA License: 36234132) shares: “Trough levels guide dose adjustments but must be weighed against renal function, hepatic metabolism, and concurrent drug interactions. Use this panel as a decision-support tool alongside your transplant team’s clinical judgment; never alter your regimen based solely on lab values.”
Medication Advisory – Do Not Alter Therapy Independently
Critical Instruction: Do not discontinue or change your prescribed immunosuppressant medication without your doctor’s explicit instruction. Abrupt cessation can trigger acute graft rejection. Always present the complete medication history, including over-the-counter supplements, to your phlebotomist and evaluating clinician.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active febrile illness (>38 °C), uncontrolled bleeding disorder, severe anaemia (Hb <8 g/dL), or current COVID-19 infection without physician clearance.
- Emergency Red Flags: Seek immediate care if you develop graft tenderness, decreased urine output, shortness of breath, or signs of systemic infection within 48 hours of sampling.
- Minors: In accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability, a parent or legal guardian must provide written consent before home collection for any patient under 18 years of age.
Patient FAQ & Clinical Guidance
1. What is the Immunosuppressant Drug Monitoring Panel (4-Drug Profile)?
This blood test quantifies trough levels of cyclosporine, tacrolimus, sirolimus, and everolimus using LC-MS/MS. Results help your transplant physician fine-tune dosing to prevent organ rejection and avoid drug toxicity.
2. How should I prepare for the home blood collection?
Schedule the collection immediately before your next scheduled dose (trough timing). Provide the phlebotomist with the exact date, time, and amount of your last dose, as well as your dosing interval.
3. When will I receive my results and clinical interpretation?
Samples received by 5:00 PM are reported the same day. A DHA-licensed general practitioner will call you to explain the results and recommend correlating them with your transplant specialist.
4. Can I take my medication on the morning of the test?
Withhold your morning dose until after the blood draw unless your doctor instructs otherwise. The test requires a trough sample taken just before your next dose for accurate interpretation.
5. What factors can affect immunosuppressant drug levels?
Drug levels can be influenced by changes in kidney or liver function, gastrointestinal health, concurrent medications (including antifungals, antibiotics, and antacids), and dietary interactions such as grapefruit juice. Always report any new prescriptions or supplements to your transplant team.
UAE Regulatory & Data Privacy Adherence
All laboratory processes comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient results are encrypted in transit and at rest, with access restricted to authorised clinicians only.
Clinical & Logistical Metadata
| Test Name | Immunosuppressant Drug Monitoring Panel (4-Drug Profile) |
| Price (AED) | 1,800 AED |
| Turnaround Time | Same-day (samples received by 5:00 PM) |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) |
| ICD-10-CM Code | Z79.899, Z94.0, Z94.1 |
| LOINC Code | 96312-6 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians